Skip to main content
VapingAddictionDigital healthMental healthBehavioralChildren's healthBehavioral

What this study is

The goal of this randomized controlled trial is to evaluate a psychosocial school-based hybrid intervention which includes traditional classroom sessions and online e-learning modules to reduce risk of vaping and prescription drug misuse as part of a broader positive youth development substance use prevention model. Upper elementary schools (N=30) will be randomized to either an intervention group that will receive a hybrid intervention or a treatment-as-usual control group that will receive existing health education programming. At the end of the intervention period, and at 6- and 12-month follow-up assessments, both groups will be compared on changes in behaviors, norms, attitudes, and knowledge regarding vaping and prescription medication use.

The main questions the trial aims to answer are:

  • Does the intervention lower risk of vaping and prescription drug misuse?
  • Does the intervention increase pro-health norms, attitudes, and knowledge regarding vaping and prescription drug misuse?

Participants will:

  • Attend 1 classroom session per week for 6 weeks (lecture, discussion, small group activities, skills practice).
  • Complete 1 e-learning module per week for 6 weeks (animated didactic content).
  • Students attending schools randomized to the control group will attend existing health education programming.

What's being tested

  • School-based Hybrid Intervention to Prevent Vaping and Prescription Drug Misuse

    Intervention · BEHAVIORAL

    Psychosocial school-based hybrid intervention which includes traditional classroom sessions and online e-learning modules to reduce risk of vaping and prescription drug misuse among upper elementary school students.

Study details

Sponsor
Christopher Williams
Conditions
Vaping · E Cig Use · Prescription Drug Misuse
Enrolling
3,000 people
Starts
2026-01
Est. completion
2028-08
Design
Open-label, randomized, parallel groups
Record
View on ClinicalTrials.gov ↗